BioNTech SE

Equity-NMS: BNTX

Healthcare | Biotechnology

$89.92-4.94 (March 19, 2026)

BioNTech SE Chart

BioNTech SE Performance

Days Range

Previous Close: $94.86
Open: $93.5
EPS(TTM): -5.39
Shares O/S: 251.33 M
Day's Range$89.86 - $93.77
52W Range$79.52 - $124
Market Cap22.6 B

About BioNTech SE

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.

Frequently Asked Questions

BioNTech SE (BNTX) share price as of March 19, 2026 is $89.92. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the BioNTech SE (BNTX) Share by opening an international trading account with Angel One.
Purchasing BioNTech SE (BNTX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying BioNTech SE (BNTX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of BioNTech SE (BNTX) or any other US company shares in Angel One for any dollar amount.
The market capitalization of BioNTech SE on February 11, 2026, is $22.6 B.
BioNTech SE operates in the Healthcare sector, specifically in the Biotechnology industry.
In order to invest in BioNTech SE (BNTX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Open Free Demat Account!
Join our 3.5 Cr+ happy customers